Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Posatirelin for the treatment of degenerative and vascular dementia: results of explanatory and pragmatic efficacy analyses.
Gasbarrini G, Stefanini G, Addolorato G, Foschi F, Ricci C, Bertolotti P, Voltolini G, Bonavita E, Bertoncelli R, Renzi G, Bianchini G, Bonaiuto S, Giannandrea E, Cavassini G, Mazzini V, Chioma V, Marzara G, D'Addetta G, Totaro G, Dalmonte E, Tassini D, Giungi F, De Nitto C, Di Fazio G, Tessitore A, Guadagnino M, Tessitore E, Spina P, Luppi M, Bignamini A, Peracino L, Fiorentino M, Beun-Garbe D, Poli A, Ambrosoli L, Girardello R. Gasbarrini G, et al. Among authors: bianchini g. Arch Gerontol Geriatr. 1998 Jan-Feb;26(1):33-47. doi: 10.1016/s0167-4943(97)00029-0. Arch Gerontol Geriatr. 1998. PMID: 18653124
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, Gelber RD, de Azambuja E, Fielding A, Balmaña J, Domchek SM, Gelmon KA, Hollingsworth SJ, Korde LA, Linderholm B, Bandos H, Senkus E, Suga JM, Shao Z, Pippas AW, Nowecki Z, Huzarski T, Ganz PA, Lucas PC, Baker N, Loibl S, McConnell R, Piccart M, Schmutzler R, Steger GG, Costantino JP, Arahmani A, Wolmark N, McFadden E, Karantza V, Lakhani SR, Yothers G, Campbell C, Geyer CE Jr; OlympiA Clinical Trial Steering Committee and Investigators. Tutt ANJ, et al. N Engl J Med. 2021 Jun 24;384(25):2394-2405. doi: 10.1056/NEJMoa2105215. Epub 2021 Jun 3. N Engl J Med. 2021. PMID: 34081848 Free PMC article. Clinical Trial.
Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer.
Bianchini G, Kiermaier A, Bianchi GV, Im YH, Pienkowski T, Liu MC, Tseng LM, Dowsett M, Zabaglo L, Kirk S, Szado T, Eng-Wong J, Amler LC, Valagussa P, Gianni L. Bianchini G, et al. Breast Cancer Res. 2017 Feb 9;19(1):16. doi: 10.1186/s13058-017-0806-9. Breast Cancer Res. 2017. PMID: 28183321 Free PMC article. Clinical Trial.
290 results